This paradoxical effect is the core of our labs research focus.
This unique formulation allows for precise dosing and may be more comfortable for those who struggle with injections
Bandaruk, Y., Mukai, R
Hwang J, Yoo JA, Yoon H, Han T, Yoon J, An S, et al
Key Background The weight loss drug market is dominated by Novo Nordisk and Eli Lilly, pharmaceutical titans whose diabetes and obesity injections Ozempic, Wegovy, Zepbound and Mounjaro are in high demand (and often limited supply) around the world
This secondary binding site may underlie some of the peptide's reported cytoprotective and anti-inflammatory properties observed in preclinical models, though the clinical significance remains under investigation